Kidney function and blood biomarkers of Alzheimer’s disease and neurodegeneration: a systematic review and meta-analysis
作者
Rebeca Oliveira da Silva,Victor Costa Guido Santos,Luís Gabriel de Sousa Fontenele,Beatriz Gonçalves da Silva Miroski,Bruno Leal Rodrigues,Gabriela Gama Carneiro Braga,Diogo Haddad Santos,Ana Letícia Amorim de Albuquerque
标识
DOI:10.65034/anpabstract_cbn261011
摘要
Background: Blood biomarkers of neurodegeneration and Alzheimer’s disease (AD) are increasingly used for early detection and risk stratification; however, systemic conditions such as reduced kidney function may influence their circulating concentrations and complicate their interpretation. Objective: To evaluate the association between reduced kidney function and blood levels of biomarkers related to AD and neurodegeneration in older adults. Methods: A systematic review and meta-analysis of patients based observational studies was conducted. Searches were performed in PubMed, Web of Science, and Embase on January 19, 2026. Studies including adults aged 50 years or older without dementia at baseline and with available measurements of kidney function and blood biomarkers were eligible. Reduced kidney function was primarily defined as an estimated glomerular filtration rate below 60 mL/min/1.73 m². Biomarkers of interest included neurofilament light chain, total tau, phosphorylated tau, glial fibrillary acidic protein, and amyloid-beta markers. Mean differences between individuals with reduced and preserved kidney function were pooled using random-effects models. Results: The search identified 3,000 records, of which 1,895 remained after duplicate removal. Individuals with reduced kidney function showed significantly higher circulating levels of neurofilament light chain (mean difference 14.36; 95% confidence interval 6.22–22.50) and total tau (mean difference 19.33; 95% confidence interval 17.71–20.94) compared with those with preserved kidney function. No statistically significant differences were observed for phosphorylated tau (mean difference 0.71; 95% confidence interval −1.10 to 4.66) or for the amyloid-beta 42/40 ratio (mean difference −0.00; 95% confidence interval −0.01 to 0.00). Moderate to high heterogeneity was observed across some analyses. Conclusion: Reduced kidney function is associated with higher circulating levels of neurodegeneration biomarkers, particularly neurofilament light chain and total tau. These findings suggest that kidney function should be considered when interpreting blood biomarkers used in the evaluation of neurodegeneration and AD.